NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 23rd Dec 2025 NOVO-B STOCK Price closed @ 331.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 320.00 Change Price %
High 337.40 1 Day 28.05 9.24
Low 318.00 1 Week 10.40 3.24
Close 331.55 1 Month 17.90 5.71
Volume 16059690 1 Year -416.05 -55.65
52 Week High 790.30 | 52 Week Low 287.00
 
CO Denmark Most Active Stocks
NOVO-B 331.55 9.24%
SAS 0.01 0.00%
CONFRZ 0.02 0.00%
VJBA 7.33 0.41%
ORSTED 118.70 1.28%
SHAPE 2.10 10.53%
VWS 170.70 0.89%
GREENH 0.41 -6.82%
LEDIBOND 0.03 -25.00%
ASTRLS 1.15 8.49%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
MONSO 0.16 23.08%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
SHAPE 2.10 10.53%
NOVO-B 331.55 9.24%
ASTRLS 1.15 8.49%
GREENM 101.00 7.45%
 
CO Denmark Top Losers Stocks
LEDIBOND 0.03 -25.00%
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE368.93
RESISTANCE356.94
RESISTANCE349.53
RESISTANCE342.12
SUPPORT320.98
SUPPORT313.57
SUPPORT306.16
SUPPORT294.17
 
NOVO-B Forecast December 2025
4th UP Forecast549.11
3rd UP Forecast479.34
2nd UP Forecast436.21
1st UP Forecast393.08
1st DOWN Forecast270.02
2nd DOWN Forecast226.89
3rd DOWN Forecast183.76
4th DOWN Forecast113.99
 
NOVO-B Weekly Forecast
4th UP Forecast439.65
3rd UP Forecast404.98
2nd UP Forecast383.55
1st UP Forecast362.12
1st DOWN Forecast300.98
2nd DOWN Forecast279.55
3rd DOWN Forecast258.12
4th DOWN Forecast223.45
 
NOVO-B Forecast2025
4th UP Forecast1355.17
3rd UP Forecast1026.89
2nd UP Forecast823.97
1st UP Forecast621.05
1st DOWN Forecast42.05
2nd DOWN Forecast-160.87
3rd DOWN Forecast-363.79
4th DOWN Forecast-692.07
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service